2Oliver A, Weigel LM, Rasheed JK, et al. Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coli[J].Antimicrob Agents Chemother, 2002, 46(12): 3829-3836.
3National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing [S].Eleventh informational supplement. NCCLS, M100-S11,2001.
4Levy SB. Active efflux, a common mechanism for biocide and antibiotic resistanceFJ]. Symp Ser Soc Appl Microbiol, 2002,(31): 65S-71S.
5Inoue M. Drug-resistant bacteria of current topics and their resistance mechanisms-ESBLs[J]. Rinsho BYori, 2000, Suppl 111: 36-39.
6Murray P R, Baron E J, Pfalhr M A, et al. Manual of clinical microbiology. 6th ed. Washington DC:American Society Microbiology, 1995. 308.
7Caballero-Granado F J,Cisneros J M.et al.Comparntive atudy of Bacteremisa Caused by Enterucoccus S P P. With saul without high-level Resistance to grentamicin. J Clin Microbiol, 1998,36(2) :52O.
8Stevenson K B, Murray E W, Sanbbi F A. Clinical analysis of nosocomial infecttions caused by entercpccis. Clin Infect Dis,1994,18(1) :233.
